ERBB2 and breast carcinoma: The HER2/neu receptor is an epidermal growth factor (EGF) family transmembrane tyrosine kinase that is amplified and overexpressed in 20%–30% of breast cancers (Yarden and Sliwkowski, 2001; Zhou and Hung, 2003).